×
×
homepage logo
LOGIN
SUBSCRIBE

COVID-19

AstraZeneca sees $4B in COVID vaccine sales as revenue soars

LONDON (AP) — AstraZeneca recorded a big jump in revenue on Thursday as it begins to take a profit from its coronavirus vaccine for the first time. The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at constant exchange rates. Part of the boost ...

Philippines welcomes back foreign travelers after 2 years

MANILA, Philippines (AP) — The Philippines lifted a nearly two-year ban on foreign travelers Thursday in a lifesaving boost for its tourism and related industries as an omicron-fueled surge eases. Foreign travelers from 157 countries with visa-free arrangements with the Philippines who have ...

Japan OKs Pfizer COVID-19 oral pills amid surging infections

TOKYO (AP) — Japan has granted fast-track approval to U.S. drug maker Pfizer Inc.'s COVID-19 pill, the heath minister said Thursday, as the country struggles to slow fast-spreading omicron infections. The approval came less than a month after Pfizer applied in mid-January, an exceptional ...

Blockades by virus protest convoys banned in Paris, Brussels

PARIS (AP) — Authorities in France and Belgium on Thursday banned road blockades threatened by groups organizing online against COVID-19 restrictions, in part inspired by protesters in Canada. Citing "risks of trouble to public order," the Paris police department banned protests aimed at ...

Novavax says protein vaccine works for kids as young as 12

Novavax announced Thursday that its COVID-19 vaccine proved safe and effective in a study of 12- to 17-year-olds. Novavax makes a protein-based vaccine -- a different type than the most widely used shots -- that's a late arrival to the COVID-19 arsenal. Its shots have been cleared for use ...

US buys 600K doses of new COVID antibody awaiting clearance

WASHINGTON (AP) — Addressing diminished treatment options in the omicron wave, the Biden administration has purchased enough of a yet-to-be approved antibody drug to treat 600,000 COVID-19 patients, officials said Thursday. The new monoclonal antibody from pharmaceutical giant Eli Lilly ...